Ventilator-associated tracheobronchitis, or VAP? (CHEST) - PulmCCM
Advertisement
Dec 182011
 

For one year, Dallas et al prospectively followed 2,060 intubated MICU/SICU patients at Barnes-Jewish, and concluded that 83 (4%) developed VAP and 28 (1.4%) got VAT, which was defined as fever and 100,000 CFUs in tracheal secretions, without an infiltrate. By their reckoning, a third of VATs progressed to VAPs. Pathogens (mainly MDR bacteria) overlapped. No differences in mortality were seen. In light of evolving “never event” reimbursement issues, the associated editorial’s title is priceless: “VAT: Public-Reporting Scam or Important Clinical Infection?” CHEST 2011;139:513-518.

Liked this post? Get a weekly email update (no spam, ever), and explore our library of clinical guidelines, practice updatesreview articles. and board review questions.

PulmCCM is an independent publication, not affiliated with or endorsed by any other organization, society or journal referenced on the website.

Authors: contribute your work to PulmCCM Journal or in a guest blog post.

Leave a Comment